| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
Department of Haematology, Imperial College School of Medicine, Hammersmith Hospital, London W12 0NN, United Kingdom
During routine two-fusion fluorescence in situ hybridization analysis of patients with blast crisis of chronic myeloid leukemia (CML), we observed that yeast artificial chromosome 29GD7, which is distal to BCR at 22q11, failed to hybridize to the 9q+ derivative chromosome in 3 of 11 (27%) cases. This deleted region is close to hSNF5/INI1 (SMARCB1), a gene that encodes a widely expressed component of the SWI/SNF chromatin remodeling complex and that suffers biallelic mutations in malignant rhabdoid tumors. To determine whether hSNF5/INI1 was also deleted in patients with CML, we performed fluorescence in situ hybridization analysis with a specific cosmid probe. Deletion of hSNF5/INI1 on the 9q+ chromosome was found in 9 of 25 (36%) cases in blast crisis (lymphoid, n = 3; myeloid, n = 6). For the three of these nine patients for whom material was available prior to transformation, deletions were also seen in chronic phase, indicating that they are early events. Analysis of an additional 21 patients in chronic phase revealed heterozygous loss of hSNF5/INI1 in 5 (24%) cases. Of the 14 patients who had hSNF5/INI1 deletions, 7 showed a mosaic pattern of hybridization in which only a proportion of CML cells that harbored both the t(9;22) derivative chromosomes had a deletion, indicating that loss of hSNF5/INI1 was acquired during the course of the disease. Single-strand conformation polymorphism analysis of all nine hSNF5/INI1 exons and splice junctions failed to reveal any mutations for 31 patients in transformation, including 8 who had deletions, although two polymorphisms were identified. We conclude that deletions of hSNF5/INI1 are frequent in patients with CML. Such deletions may be associated with reduced levels of hSNF5/INI1 expression, which could contribute to leukemogenesis by altering chromatin-mediated transcriptional control. Alternatively, the deletions could target another unidentified gene at 22q11 that plays a role in the pathogenesis of CML.
This article has been cited by other articles:
|
|
 |
|
  B. A. McKinley and M. V. Sukhodolets Escherichia coli RNA polymerase-associated SWI/SNF protein RapA: evidence for RNA-directed binding and remodeling activity Nucleic Acids Res., December 18, 2007; 35(21): 7044 - 7060. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kreil, M. Pfirrmann, C. Haferlach, K. Waghorn, A. Chase, R. Hehlmann, A. Reiter, A. Hochhaus, N. C. P. Cross, and for the German Chronic Myelogenous Leukemia (CML) Heterogeneous prognostic impact of derivative chromosome 9 deletions in chronic myelogenous leukemia Blood, August 15, 2007; 110(4): 1283 - 1290. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. G.J. Vries, V. Bezrookove, L. M.P. Zuijderduijn, S. K. Kia, A. Houweling, I. Oruetxebarria, A. K. Raap, and C. P. Verrijzer Cancer-associated mutations in chromatin remodeler hSNF5 promote chromosomal instability by compromising the mitotic checkpoint Genes & Dev., March 15, 2005; 19(6): 665 - 670. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Quintas-Cardama, H. Kantarjian, M. Talpaz, S. O'Brien, G. Garcia-Manero, S. Verstovsek, M. B. Rios, K. Hayes, A. Glassman, B. N. Bekele, et al. Imatinib mesylate therapy may overcome the poor prognostic significance of deletions of derivative chromosome 9 in patients with chronic myelogenous leukemia Blood, March 15, 2005; 105(6): 2281 - 2286. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. B. Zraly, D. R. Marenda, and A. K. Dingwall SNR1 (INI1/SNF5) Mediates Important Cell Growth Functions of the Drosophila Brahma (SWI/SNF) Chromatin Remodeling Complex Genetics, September 1, 2004; 168(1): 199 - 214. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. J. Guidi, T. M. Veal, S. N. Jones, and A. N. Imbalzano Transcriptional Compensation for Loss of an Allele of the Ini1 Tumor Suppressor J. Biol. Chem., February 6, 2004; 279(6): 4180 - 4185. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Oruetxebarria, F. Venturini, T. Kekarainen, A. Houweling, L. M. P. Zuijderduijn, A. Mohd-Sarip, R. G. J. Vries, R. C. Hoeben, and C. P. Verrijzer p16INK4a Is Required for hSNF5 Chromatin Remodeler-induced Cellular Senescence in Malignant Rhabdoid Tumor Cells J. Biol. Chem., January 30, 2004; 279(5): 3807 - 3816. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. J. P. Huntly, F. Guilhot, A. G. Reid, G. Vassiliou, E. Hennig, C. Franke, J. Byrne, A. Brizard, D. Niederwieser, J. Freeman-Edward, et al. Imatinib improves but may not fully reverse the poor prognosis of patients with CML with derivative chromosome 9 deletions Blood, September 15, 2003; 102(6): 2205 - 2212. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. J. P. Huntly, A. Bench, and A. R. Green Double jeopardy from a single translocation: deletions of the derivative chromosome 9 in chronic myeloid leukemia Blood, August 15, 2003; 102(4): 1160 - 1168. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T S K Wan, S K Ma, W Y Au, and L C Chan Derivative chromosome 9 deletions in chronic myeloid leukaemia: interpretation of atypical D-FISH pattern J. Clin. Pathol., June 1, 2003; 56(6): 471 - 474. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Hwang, D. Lee, Y. Gwack, H. Min, and J. Choe Kaposi's sarcoma-associated herpesvirus K8 protein interacts with hSNF5 J. Gen. Virol., March 1, 2003; 84(3): 665 - 676. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. R. Marenda, C. B. Zraly, Y. Feng, S. Egan, and A. K. Dingwall The Drosophila SNR1 (SNF5/INI1) Subunit Directs Essential Developmental Functions of the Brahma Chromatin Remodeling Complex Mol. Cell. Biol., January 1, 2003; 23(1): 289 - 305. [Abstract] [Full Text]
|
|
|
|
|
|
K. Roy, I. L. de la Serna, and A. N. Imbalzano The Myogenic Basic Helix-Loop-Helix Family of Transcription Factors Shows Similar Requirements for SWI/SNF Chromatin Remodeling Enzymes during Muscle Differentiation in Culture J. Biol. Chem., September 6, 2002; 277(37): 33818 - 33824. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. J. P. Huntly, A. J. Bench, E. Delabesse, A. G. Reid, J. Li, M. A. Scott, L. Campbell, J. Byrne, E. Pinto, A. Brizard, et al. Derivative chromosome 9 deletions in chronic myeloid leukemia: poor prognosis is not associated with loss of ABL-BCR expression, elevated BCR-ABL levels, or karyotypic instability Blood, May 29, 2002; 99(12): 4547 - 4553. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. E. Neely, A. H. Hassan, C. E. Brown, L. Howe, and J. L. Workman Transcription Activator Interactions with Multiple SWI/SNF Subunits Mol. Cell. Biol., March 15, 2002; 22(6): 1615 - 1625. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. G. Reid, B. J. P. Huntly, E. Hennig, D. Niederwieser, L. J. Campbell, N. Bown, N. Telford, H. Walker, C. D. Grace, M. W. Deininger, et al. Deletions of the derivative chromosome 9 do not account for the poor prognosis associated with Philadelphia-positive acute lymphoblastic leukemia Blood, March 15, 2002; 99(6): 2274 - 2275. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Wild, P. Langer, A. Ramaswamy, B. Chaloupka, and D. K. Bartsch A Novel Insulinoma Tumor Suppressor Gene Locus on Chromosome 22q with Potential Prognostic Implications J. Clin. Endocrinol. Metab., December 1, 2001; 86(12): 5782 - 5787. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. de la Fuente, K. Merx, E. J. Steer, M. Muller, R. M. Szydlo, O. Maywald, U. Berger, R. Hehlmann, J. M. Goldman, N. C. P. Cross, et al. ABL-BCR expression does not correlate with deletions on the derivative chromosome 9 or survival in chronic myeloid leukemia Blood, November 1, 2001; 98(9): 2879 - 2880. [Full Text] [PDF]
|
|
|
|
|
|
B. J. P. Huntly, A. G. Reid, A. J. Bench, L. J. Campbell, N. Telford, P. Shepherd, J. Szer, H. M. Prince, P. Turner, C. Grace, et al. Deletions of the derivative chromosome 9 occur at the time of the Philadelphia translocation and provide a powerful and independent prognostic indicator in chronic myeloid leukemia Blood, September 15, 2001; 98(6): 1732 - 1738. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Kolomietz, J. Al-Maghrabi, S. Brennan, J. Karaskova, S. Minkin, J. Lipton, and J. A. Squire Primary chromosomal rearrangements of leukemia are frequently accompanied by extensive submicroscopic deletions and may lead to altered prognosis Blood, June 1, 2001; 97(11): 3581 - 3588. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. J. Druker, C. L. Sawyers, R. Capdeville, J. M. Ford, M. Baccarani, and J. M. Goldman Chronic Myelogenous Leukemia Hematology, January 1, 2001; 2001(1): 87 - 112. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A Johnson Chromatin modification and disease J. Med. Genet., December 1, 2000; 37(12): 905 - 915. [Full Text]
|
|
|
|
 |
|
 A. K. C. Wong, F. Shanahan, Y. Chen, L. Lian, P. Ha, K. Hendricks, S. Ghaffari, D. Iliev, B. Penn, A.-M. Woodland, et al. BRG1, a Component of the SWI-SNF Complex, Is Mutated in Multiple Human Tumor Cell Lines Cancer Res., November 1, 2000; 60(21): 6171 - 6177. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
